GemOx plus RT and 5FU plus GemOx for pancreatic cancer; the GOFURTGO trial

Lead researcher

A/Prof David Goldstein (NSW), Dr Sean Bydder (WA), Dr Jennifer Harvey (Qld), Dr Sudarshan (Sid) Selva-Nayaram (SA), Dr Craig Underhill (Vic)

Institution

Border Medical Oncology

Years funded

2007

There is currently no optimum treatment for patients with advanced or recurrent pancreatic cancer. Radiotherapy combined with chemotherapy has been shown to improve survival time significantly but newer approaches to treatment are still needed. This study will provide additional answers about the role of radiotherapy in combination with chemotherapy.

Award / Duration

Duration: 2007

Funding

$6,000

Updated: